Nuwellis (NUWE) Change in Acquisitions & Divestments (2022)

Nuwellis (NUWE) posted Change in Acquisitions & Divestments of $14.8 million for Q4 2022.

Nuwellis (NUWE) Change in Acquisitions & Divestments (2022) Analysis & Trends

Nuwellis' Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $14.8 million for Q4 2022.

  • Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $14.8 million in Q4 2022, while the trailing twelve-month figure through Sep 2024 was $14.8 million (changed N/A YoY) and the FY2023 annual result came in at $578000.0, down 96.11% from the prior year.
  • Change in Acquisitions & Divestments was $14.8 million for Q4 2022 at Nuwellis.
  • Across five years, Change in Acquisitions & Divestments topped out at $14.8 million in Q4 2022 and bottomed at $14.8 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.82 Bn 176.53 Bn 6.27 Bn
2 Stryker 129.01 Bn 126.13 Bn 3.81 Bn
3 Medtronic 108.52 Bn 99.30 Bn 6.41 Bn
4 Boston Scientific 68.59 Bn 67.14 Bn 3.61 Bn
5 Edwards Lifesciences 48.35 Bn 44.68 Bn 1.29 Bn
6 Dexcom 28.35 Bn 27.23 Bn 750.30 Mn
7 GE HealthCare Technologies 28.11 Bn 25.82 Bn 1.98 Bn
8 Smith & Nephew 26.89 Bn 26.32 Bn -
9 Koninklijke Philips 24.28 Bn 21.15 Bn 2.07 Bn
10 Nuwellis 115,607.70 -1.97 Mn 1.68 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 14.85 Mn
Dec 31, 2022 14.85 Mn